| Pharmaceutical active ingredients: |
| Toremifene Citrate |
| Available forms, composition and doses of Farestone: |
| Tablets; Oral; Toremifene Citrate 20 mgTablets; Oral; Toremifene Citrate 60 mg |
| Farestone medical category: |
| Human:Anticancer drugsSelective estrogen receptor modulators |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L02BA02 - Toremifene |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Related documents and information about Farestone: |
| Fareston prescribing information (PDF) |